Ian B. Wilkinson

Apr 4, 2024 | academic.oup.com | Ian B. Wilkinson |Tim Raine |Kate Wiles |Dearbhla M Kelly |Iain J McGurgan |Peter Hateley

Unique among medical texts, the Oxford Handbook of Clinical Medicine is a complete and concise guide to the core areas of medicine that also encourages thinking about the world from the patient's perspective, offering a holistic, patient-centred approach. Loved and trusted by millions for over three decades, the Oxford Handbook of Clinical Medicine continues to be a truly indispensable companion for the practice of modern medicine.

Feb 29, 2024 | bjgp.org | Terry McCormack |Sarah Partridge |Ian B. Wilkinson

There are potentially 13 million adults in the UK and Ireland who have raised blood pressure that requires treatment.1 While the majority of patients with hypertension are well managed in primary care, there is a significant proportion who need specialist care. Approximately 10% of patients have complex hypertension that requires specialist input,2,3 but the provision of specialist clinics is poorly distributed throughout the UK and Ireland, making access for patients inequitable.

Dec 12, 2023 | suntci.com | Ian B. Wilkinson

The elements (particularly a tropical storm) forced me to take a break recently. I am delighted to resume this week. In my last article, we commenced an analysis of the various benefits of playing chess. This week we will continue highlighting some of these truly rewarding benefits. We will, however, first look at a new piece – the Rook. The rook is worth five (5) points, making it the second most valuable piece in the chess army. It is also called a “castle”.

Oct 24, 2023 | suntci.com | Ian B. Wilkinson

In last week’s article we began looking in greater detail at the chess “battlefield”. Indeed, we looked at the “names” for the various squares on the chess board using “algebraic notation” as indicated by diagram 4. Diagram 4This week we will begin an analysis of the various chess pieces. Diagram 5Each player starts the game with 16 pieces. The most important is the king whose fate decides the game.

Oct 18, 2023 | mlo-online.com | Christina Wichmann |Ian B. Wilkinson

On October 3, 2023, the Food and Drug Administration (FDA) published its anticipated proposed rule to regulate laboratory developed tests (LDTs) as medical devices.1 The proposed rule changes the definition of in vitro diagnostic products (IVDs) at 21 CFR 809.3(a) with the underlined text below.